首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1968394

瓣環成形系統市場－全球產業規模、佔有率、趨勢、機會和預測：按應用、最終用途、地區和競爭對手分類，2021-2031年

Annuloplasty System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End Use, By Region & Competition, 2021-2031F

出版日期: 2026年01月19日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球瓣環成形術系統市場預計將從 2025 年的 4.8921 億美元成長到 2031 年的 6.8575 億美元，複合年成長率達到 5.79%。

這些系統作為植入式假體，用於心臟手術中重建和再形成心臟瓣膜環，恢復瓣膜的正常功能並防止逆流。市場成長趨勢主要受全球人口老化以及需要手術介入的瓣膜性心臟病病例增加的雙重驅動。此外，優先選擇瓣膜修復而非瓣膜置換的趨勢（主要目的是使患者擺脫終身抗凝血治療）也成為推動產業成長的主要動力。根據美國心臟協會估計，到2024年，全球非風濕性退化性二尖瓣疾病的盛行率將達到約1,550萬例，凸顯了對有效修復方案的巨大需求。

市場概覽
預測期	2027-2031
市場規模：2025年	4.8921億美元
市場規模：2031年	6.8575億美元
複合年成長率：2026-2031年	5.79%
成長最快的細分市場	二尖瓣修復
最大的市場	北美洲

限制其更廣泛市場應用的主要障礙在於有效實施瓣環成形術所需的高超外科技術。此類手術的技術複雜性要求外科醫生接受廣泛的培訓並累積豐富的經驗，因此，這些先進的修復方案僅限於專業的大型醫療機構，且在醫療發展中地區難以普及。這種對專業技術的要求造成了瓶頸，阻礙了該技術的廣泛應用，使其無法在缺乏必要醫療基礎設施的地區充分發揮潛力。

市場促進因素

二尖瓣和三尖瓣逆流的盛行率不斷上升，尤其是在老年人中，是推動市場擴張的主要動力。隨著全球老年人口的成長，退化性瓣膜疾病的發生率也隨之增加，因此，有效治療以控制症狀和預防心臟衰竭已成為亟待解決的問題。這種人口結構的變化催生了對旨在恢復瓣膜原有結構的瓣環成形術系統的強勁需求。 2025年11月發表於《美國心臟協會雜誌》（AHA 日誌）的一項題為「老年人三尖瓣逆流的盛行率、臨床相關性和預後影響」的研究估計，一般人群中中重度三尖瓣逆流的盛行率為3%，且該數值老齡化成長而顯著增加。

同時，微創和經導管瓣環成形術系統的技術進步正在從根本上改變治療格局，為開胸手術提供了切實可行的替代方案。基於導管的輸送系統的創新使得即使在高風險患者中也能實現精準植入，從而擴大了目標患者群體，並加速了已開發市場的普及。這種創新的快速成長也體現在產業領導者的財務表現中。例如，2025年1月，雅培公司報告稱，其結構性心臟病業務部門2024年全年銷售額成長17%，達到22.5億美元，這主要得益於新型修復技術的應用。同樣，2025年，愛德華生命科學公司宣布，其經導管二尖瓣和三尖瓣治療業務部門2024年第四季度銷售額成長88%，達到1.05億美元，這表明這些先進治療方法正在迅速普及。

市場挑戰

瓣環成形術術所需的高度專業化的外科技術是全球瓣環成形術系統市場成長的主要障礙。瓣膜修復比瓣膜置換術技術更為複雜，要求外科醫師具備精湛的技能，才能精確重建瓣環並恢復其生理功能。這種陡峭的學習曲線限制了合格醫生的數量，導致此類手術集中在病例量大的專科醫療中心。因此，許多醫院，尤其是在新興市場和病例量較小的醫療機構，由於缺乏複雜修復所需的人員，不得不選擇瓣膜置換術，這阻礙了瓣環成形術裝置的普及。

人員短缺是限制市場擴張的主要瓶頸，阻礙了市場拓展以應對日益成長的瓣膜性心臟病需求。外科醫師數量無法跟上患者需求的成長速度，直接限制了瓣環成形術術的發展。根據美國醫學院協會 (AAMC) 2024 年的預測，到 2036 年，外科專家的缺口將達到 10,100 至 19,900 人。高素質外科醫生的供應與臨床干預需求之間日益擴大的差距將限制市場擴張，因為如果沒有足夠的合格用戶，該行業就無法有效地部署其技術。

市場趨勢

機器人輔助瓣膜修復平台的日益普及，克服了傳統微創手術在視野和操作性方面的局限性，顯著影響著市場動態。這些系統使外科醫生能夠透過微小切口高精度地完成複雜的瓣環成形術，有效彌合了開胸手術和微創手術療效之間的差距。從應用指標來看，這些先進外科技術的日益普及顯而易見。根據直覺外科公司（Intuitive Surgical）於2025年1月發布的2024年第四季財報，全球達文西手術數量較2023年第四季成長約18%，反映出機器人技術在一般外科和心臟外科領域的快速應用。

同時，將3D列印技術應用於病患特異性器械客製化和術前規劃，正成為瓣環成形術流程中的關鍵環節。透過利用患者影像數據產生解剖學上精確的模型，臨床醫生可以最佳化環的尺寸，並在術前模擬植入的位置，從而減少術中誤差，提高修復體的長期耐久性。這種向個人化醫療製造的轉變正在推動相關生態系統的顯著成長。根據MaterialEyes於2025年2月發布的2024年第四季及全年財報，該公司醫療保健業務部門2024年全年營收成長了14.8%，反映出複雜臨床手術中對積層製造解決方案的需求日益成長。

The Global Annuloplasty System Market is projected to expand from USD 489.21 Million in 2025 to USD 685.75 Million by 2031, achieving a compound annual growth rate (CAGR) of 5.79%. These systems serve as implantable prosthetic devices used in cardiac surgery to reconstruct and reshape the heart valve annulus, thereby restoring proper valve function and preventing regurgitation. The market's upward trajectory is heavily driven by the aging global population and a concurrent rise in valvular heart conditions that require surgical intervention. Furthermore, the clinical preference for valve repair over replacement-primarily to spare patients from lifelong anticoagulation therapy-acts as a major catalyst for industry growth. According to the American Heart Association, the global prevalence of nonrheumatic degenerative mitral valve disease was approximately 15.5 million cases in 2024, highlighting the substantial demand for effective repair solutions.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 489.21 MIllion
Market Size 2031	USD 685.75 MIllion
CAGR 2026-2031	5.79%
Fastest Growing Segment	Mitral Valve Repair
Largest Market	North America

A significant barrier restricting broader market adoption is the high level of surgical expertise required to perform effective annuloplasty procedures. The technical complexity of these operations necessitates extensive surgeon training and experience, which confines the availability of these advanced repair options to specialized, high-volume centers and limits accessibility in developing healthcare regions. This requirement for specialized skills creates a bottleneck that hinders widespread implementation, preventing the technology from reaching its full potential in areas lacking the necessary medical infrastructure.

Market Driver

The escalating prevalence of mitral and tricuspid valve regurgitation, particularly among the aging demographic, acts as a primary engine for market expansion. As the global geriatric population grows, the incidence of degenerative valvular pathologies rises, creating a critical need for effective repair interventions to manage symptoms and prevent heart failure. This demographic shift sustains a strong demand for annuloplasty systems designed to restore native valve geometry. According to a study published in AHA Journals in November 2025 titled 'Prevalence, Clinical Correlates, and Prognostic Impact of Tricuspid Regurgitation in Older Adults,' the estimated prevalence of moderate to severe tricuspid regurgitation in the general population is 3%, a figure that increases significantly with age.

Simultaneously, technological advancements in minimally invasive and transcatheter annuloplasty systems are fundamentally reshaping the treatment landscape by offering viable alternatives to open-heart surgery. Innovations in catheter-based delivery systems enable precise implant positioning in high-risk patients, thereby expanding the addressable patient pool and accelerating adoption rates in developed markets. This surge in innovation is reflected in the financial performance of key industry players. For instance, Abbott reported in January 2025 that their Structural Heart unit sales increased by 17% for the full year 2024, reaching $2.25 billion, largely driven by the adoption of new repair technologies. Similarly, Edwards Lifesciences noted in 2025 that sales for their Transcatheter Mitral and Tricuspid Therapies division grew 88% in the fourth quarter of 2024 to $105 million, evidencing the rapid uptake of these advanced therapies.

Market Challenge

The high level of specialized surgical expertise required to perform annuloplasty procedures constitutes a substantial barrier hindering the growth of the Global Annuloplasty System Market. Valve repair is technically more demanding than valve replacement, requiring surgeons to possess advanced skills to precisely reconstruct the annulus and restore physiological function. This steep learning curve limits the number of qualified operators, resulting in a concentration of these procedures solely in high-volume, specialized medical centers. Consequently, many hospitals, particularly in emerging markets or lower-volume facilities, default to valve replacement surgeries simply because they lack the requisite personnel to perform complex repairs, thereby stifling the adoption of annuloplasty devices.

This workforce constraint creates a significant bottleneck that prevents the market from meeting the rising prevalence of valvular disease. The inability to scale the surgical workforce at the same pace as patient demand directly caps the procedural volume for annuloplasty systems. According to projections from the Association of American Medical Colleges in 2024, a shortage of between 10,100 and 19,900 physicians in surgical specialties is anticipated by 2036. This widening gap between the availability of highly trained surgeons and the clinical need for intervention limits market expansion, as the industry cannot deploy its technologies effectively without a sufficient base of capable users.

Market Trends

The increased utilization of robotic-assisted valve repair platforms is significantly influencing market dynamics by overcoming the visualization and dexterity limitations associated with conventional minimally invasive surgery. These systems enable surgeons to perform complex annuloplasty procedures with high precision through small incisions, effectively bridging the gap between open-heart efficacy and less invasive approaches. The expanding footprint of these advanced surgical modalities is evident in adoption metrics; according to Intuitive Surgical's January 2025 report on 'Fourth Quarter 2024 Financial Results,' worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023, reflecting the rapid integration of robotic technologies into general and cardiac surgical practice.

Concurrently, the integration of 3D printing for patient-specific device customization and pre-surgical planning is becoming a critical component of the annuloplasty workflow. By generating anatomically accurate models from patient imaging, clinicians can optimize ring sizing and simulate implant placement prior to the operation, thereby reducing intraoperative errors and improving long-term repair durability. This shift toward personalized medical manufacturing is driving substantial growth in the supporting ecosystem. According to Materialise's February 2025 report on 'Fourth Quarter and Full Year 2024 Results,' revenues from the company's Medical segment grew by 14.8% for the full year 2024, underscoring the rising demand for additive manufacturing solutions in complex clinical interventions.

Key Market Players

Medtronic Plc
Abbott Laboratories, Inc.
Edwards Lifesciences Corporation
Corcym Group
Labcor Laboratorios Ltda
Affluent Medical SA
Valcare Medical
Braile Biomedica
LivaNova PLC
Micro Interventional Devices, Incorporated

Report Scope

In this report, the Global Annuloplasty System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Annuloplasty System Market, By Application

Mitral Valve Repair
Tricuspid Valve Repair
Aortic Valve Repair

Annuloplasty System Market, By End Use

Hospitals
Ambulatory Surgical Centers
Others

Annuloplasty System Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Annuloplasty System Market.

Available Customizations:

Global Annuloplasty System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Annuloplasty System Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Mitral Valve Repair, Tricuspid Valve Repair, Aortic Valve Repair)
- 5.2.2. By End Use (Hospitals, Ambulatory Surgical Centers, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Annuloplasty System Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Annuloplasty System Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
    - 6.3.1.2.2. By End Use
- 6.3.2. Canada Annuloplasty System Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
    - 6.3.2.2.2. By End Use
- 6.3.3. Mexico Annuloplasty System Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application
    - 6.3.3.2.2. By End Use

7. Europe Annuloplasty System Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Annuloplasty System Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
    - 7.3.1.2.2. By End Use
- 7.3.2. France Annuloplasty System Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Annuloplasty System Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Annuloplasty System Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Annuloplasty System Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application
    - 7.3.5.2.2. By End Use

8. Asia Pacific Annuloplasty System Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Annuloplasty System Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
    - 8.3.1.2.2. By End Use
- 8.3.2. India Annuloplasty System Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
    - 8.3.2.2.2. By End Use
- 8.3.3. Japan Annuloplasty System Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
    - 8.3.3.2.2. By End Use
- 8.3.4. South Korea Annuloplasty System Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Annuloplasty System Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application
    - 8.3.5.2.2. By End Use

9. Middle East & Africa Annuloplasty System Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Annuloplasty System Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
    - 9.3.1.2.2. By End Use
- 9.3.2. UAE Annuloplasty System Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
    - 9.3.2.2.2. By End Use
- 9.3.3. South Africa Annuloplasty System Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application
    - 9.3.3.2.2. By End Use

10. South America Annuloplasty System Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Annuloplasty System Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
    - 10.3.1.2.2. By End Use
- 10.3.2. Colombia Annuloplasty System Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
    - 10.3.2.2.2. By End Use
- 10.3.3. Argentina Annuloplasty System Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Annuloplasty System Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Medtronic Plc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Abbott Laboratories, Inc.
15.3. Edwards Lifesciences Corporation
15.4. Corcym Group
15.5. Labcor Laboratorios Ltda
15.6. Affluent Medical SA
15.7. Valcare Medical
15.8. Braile Biomedica
15.9. LivaNova PLC
15.10. Micro Interventional Devices, Incorporated